Authors
Latest:
Does diet really play a role in acne?For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.
Latest:
An Overview of ArgyriaArgyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
Latest:
New Drugs in 2023, Patient Satisfaction, and RAD Takeaways With Melinda Gooderham, MSc, MD, FRCPCGooderham’s sessions covered upcoming AD drug approvals, patient satisfaction and QoL improvement, and RAD 2023 takeaways.
Latest:
Telehealth in 2023: What Physicians Need to KnowAnswers to some common questions about providing telehealth services in 2023.
Latest:
Glynis Ablon, MD, Reviews the Latest Innovative Treatment Pearls for Hair LossAblon presented sessions on nutrition, exosome therapy, and treating the hair-challenged patient at SCALE 2023.
Latest:
Addressing Patients' Concerns With BiosimilarsDrs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Latest:
Annual Meeting Session Highlights Clinical Pearls in Medical DermatologyA key session at the annual meeting will share practical advice and tools to better support you and your patients.
Latest:
Patient Case #1: 29-Year-Old Female With Plaque PsoriasisDawn L. Sammons, DO, FAOCD, FAAD, and Benjamin Lockshin, MD, FAAD, review a case of a female patient with a family history of plaque psoriasis.
Latest:
Expert Insights into the Safety of IsotretinoinAn expert in dermatology reviews the differences in Isotretinoin and highlights how this treatment is both highly efficacious and safe when administered and monitored properly.
Latest:
Topical Remetinostat Effective, Tolerable in Basal Cell CarcinomaThe topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.
Latest:
Rule 1 for Investing During Volatile Markets: Stick to Your PlanIn this month's financial planning column, the OJM group talks about volatile markets and how to navigate investing in uncertain times.
Latest:
Patient Case #1: AD Treatment OptionsElizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, highlight treatment options for a specific patient with AD, focusing on dupilumab.
Latest:
Pregnancy outcomes vary in women with psoriatic arthritisThe study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.
Latest:
New Long-Term KEYNOTE-716 Data Presented at ASCO 2023Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.
Latest:
FDA Grants Orphan Drug Status to ITIL-168 for MelanomaThe FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.
Latest:
Designing Your Practice With Kristina Collins, MDCollins said an office environment impacts outcomes and shared office design considerations.
Latest:
Preparing Patients for the Summer Sun: Location, Location, LocationLeading clinicians discuss sun protection best practices based on weather, climate, and travel needs.
Latest:
Acne Flares May be Worsened by Climate ChangeChanges in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.
Latest:
Advancing Medical Treatments for Vitiligo With Amit Pandya, MD, FAADPandya gives an in-depth overview of his vitiligo treatment pearls from the 2023 Pigmentary Disorders Exchange Symposium.
Latest:
Upadacitinib, Long-Term Control, and Tapinarof, Oh My!Raj Chovatiya, MD, PhD, discusses highlights from his sessions at RAD 2023 on best practices for AD management.
Latest:
Female physicians earn millions less than male counterparts, new report findsA new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.
Latest:
Acne Update: 2022’s Top 5 TrendsFresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.
